Mankind Pharma IPO: Issue subscribed 14% on Day 1; NIIs steal the show
1 year, 7 months ago

Mankind Pharma IPO: Issue subscribed 14% on Day 1; NIIs steal the show

Live Mint  

Mankind Pharma's initial public offer was subscribed 14% on Day 1. The issue received response from non-institutional investors who subscribed about 33%, retail investors who had subscribed about 10% and qualified institutional investors subscribed 8% of the allotted quota to them. The non-institutional investors' portion received bids for 19,95,968 shares against 60,08,827 on offer for this segment. The retail investors' portion received bids for 14,39,737 shares against 1,40,20,596 on offer for this segment. The issue's book-running lead managers are Kotak Mahindra Capital Company Ltd, Axis Capital Ltd, IIFL Securities Ltd, Jefferies India Private Ltd, and JP Morgan India Private Ltd.

History of this topic

NACDAC Infra IPO allotment: Step-by-step guide to check status
4 days, 19 hours ago
Swiggy's $1.4 bn IPO fully sold, institutional portion 131% subscribed
1 month, 2 weeks ago
GMP Soars on Final Day, With Strong Subscription Details
2 months ago
IPO: Western Carriers India Sees Muted Response From Investors, Check GMP, Price Band And Other Details
3 months, 1 week ago
Emcure Pharma IPO receives strong response, subscribed 67.86 times on third bidding day; Issue oversubscribed, check GMP
5 months, 2 weeks ago
Mankind Pharma promoters to offload shares to meet minimum shareholding norms
10 months, 2 weeks ago
BLS E-Services IPO: Issue fully subscribed within minutes of opening, gets 15.63 times subscription
10 months, 3 weeks ago
Innova Captab IPO: Issue booked 3.54 times on day 2; GMP steady
1 year ago
Innova Captab IPO: Issue subscribed 1.41 times on day 1; retail booked 2.13x
1 year ago
Protean eGov Tech IPO Day 2: Issue subscribed to 3.22 times; details here
1 year, 1 month ago
IPO fundraising slumps by 26% in H1 FY24 to ₹26,300 crore, shows data
1 year, 2 months ago
Valiant IPO: Issue subscribed 29.76 times on day 4; retail portion booked 16.06x
1 year, 2 months ago
Updater IPO: Issue subscribed 2.90 times on day 3; retail portion fully booked
1 year, 2 months ago
Sai Silks IPO: Issue subscribed 4.40 times on day 3, retail portion booked 88%
1 year, 3 months ago
Sai Silks IPO: Issue subscribed 33% on day 2; retail portion booked 26%
1 year, 3 months ago
Rishabh IPO: Issue subscribed 2.46 times on day 2; details here
1 year, 3 months ago
Rishabh IPO: Issue subscribed 73% on day 1, NII portion fully booked
1 year, 3 months ago
Mankind Pharma share price jumps over 8% on robust Q1 results
1 year, 4 months ago
Mankind Pharma Q1 results: Profit soars 66% on strong sales
1 year, 4 months ago
IdeaForge Technology IPO: Issue subscribed over 50 times on Day 3; check details
1 year, 5 months ago
IdeaForge Technology IPO: Issue over subscribed on Day 2; check details
1 year, 5 months ago
IdeaForge Technology IPO: Issue fully booked on Day 1; check details
1 year, 5 months ago
HMA Agro Industries IPO subscription to begin on June 20; price band fixed
1 year, 6 months ago
Mankind’s impressive listing may revive retail interest in IPOs
1 year, 7 months ago
Mankind Pharma IPO: GMP, subscription status, review, other details. Buy or not?
1 year, 7 months ago
Mankind Pharma raises ₹1,298 cr from anchor investors ahead of IPO
1 year, 8 months ago
Mankind Pharma IPO hits the market. Here are 10 key factors of the offer
1 year, 8 months ago
Mankind Pharma IPO: From key dates to price band, all you need to know
1 year, 8 months ago
Abans Holdings shares rise on market debut
2 years ago
Ami Organics IPO Allotment this Week. Know GMP, Listing Dates, Other Details
3 years, 3 months ago
Car Trade Tech and Nuvoco Vistas IPO fully subscribed on last day
3 years, 4 months ago
Car Trade Tech and Nuvoco Vistas IPOs subscribed 99% and 29% on day 2
3 years, 4 months ago
Car Trade IPO subscribed 41% on first day; Nuvoco Vistas subscribed 16%
3 years, 4 months ago
Devyani International, three other IPOs subscribed more than 20 times on the final day of bidding
3 years, 4 months ago

Discover Related